National Committee on Preventive Health

Breast Cancer Canada welcomes the Government of Canada’s announcement of the National Advisory Committee on Preventive Health Services and its commitment to evidence-based, transparent, and equitable preventive health care. Preventive health guidelines have a profound impact on the health outcomes of Canadians. For breast cancer patients, screening recommendations can influence when cancers are detected, treatment […]
Male Breast Cancer

June is Men’s Health Month, a time usually dedicated to conversations around heart health, prostate checks, and mental well-being. But there is another critical health topic that often gets left out of the locker room talk: breast cancer. While it is significantly less common in men than in women, it is no less serious. The […]
PROgress Tracker ASCO 2026

Understanding the “Burden of Worry”: New insights from PROgress Tracker Breast Cancer Registry When someone finishes active breast cancer treatment, it’s often seen as the end of the medical journey. But for many survivors, that’s not how it feels. Even after surgery, chemotherapy, or radiation are over, many people continue to live with worry: about the cancer […]
BCC’s Survivorship Strategy

What Happens After the “All Clear”? Breast Cancer Canada Calls for Urgent Action to Support Canadian Breast Cancer Survivors As more younger Canadians are being diagnosed with breast cancer and survival rates continue to improve, Breast Cancer Canada (BCC) is calling on greater government investment to address an urgent, under-funded and critical gap in cancer […]
Survivorship at ASCO 2026

Beyond the Treatment Calendar: Reflecting on Breast Cancer The American Society of Clinical Oncology (ASCO) Annual Meeting is famously known as the place where ground-breaking clinical trials make their global debut. But beneath the headlines of percentages, survival curves, and molecule names, a vital shift is taking place. At ASCO 2026, held under the global […]
BCC at ASCO: Evolving Treatment Strategies in Metastatic Breast Cancer

mBC Treatment Discussions at ASCO 2026 One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was how treatment decisions are evolving for people living with metastatic breast cancer. Researchers are increasingly focused not only on which treatments work, but also on when they should be used. Advances […]
BCC at ASCO 2026: Early Breast Cancer

One of the most discussed themes at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting was the continued shift toward personalized treatment for early breast cancer. Researchers presented new evidence demonstrating how genomic testing can help identify patients who may safely avoid chemotherapy, ensuring treatment decisions are guided by tumour biology rather than […]
Breast Cancer Canada Recommendations for the Federal Government

Written Submission for the Pre-Budget Consultations in Advance of the Upcoming Federal Budget Recommendation 1: That the Government of Canada, through the Public Health Agency of Canada, formally recognize and support implementation of Breast Cancer Canada and REAL Canadian Breast Cancer Alliance evidence-based standards of care as a national framework to promote equitable, timely, and […]
Breast Cancer Canada and REAL Canadian Breast Cancer Alliance Establish National Recommendations for Breast Cancer

For the first time in Canada, the country’s leading breast cancer experts have come together to establish national standards for breast cancer. This suite of publications released in Current Oncology today set a new benchmark for equitable, evidence-based care from staging, surgery and through treatment. “Until now, Canada has had no unified national standard for […]
Remembering Dr. Juliet Daniel

Dr. Juliet Daniel’s passing from metastatic breast cancer is a profound loss to science, to McMaster University, to the Caribbean and Canadian communities that shaped her, and especially to the Black research community she helped make more visible, and connected. She leaves a legacy defined not only by discovery, but by courage: the courage to […]

















